Back to search

Institutes outside Greece

The MUC1 mucin as a target for antibody mediated anti-tumour reactions

Abstract

dc:description

MUC1 mucins are extensive glycosylated macromolecules expressed and often secreted by various epithelial tissues. During malignant transformation, these mucins typically shift from apical to circumferential membrane localization, reflecting a loss of epithelial cell polarity and an increase in mucin secretion by tumor cells. This study investigates the expression and functional roles of MUC1 in human breast cancer cell lines, including T-47D, MCF-7wt, MCF-7adr, and MDA-231. The research aims to characterize MUC1 expression, assess its potential as a target for complement-dependent cytotoxicity, explore factors influencing MUC1 expression, identify determinants recognized by anti-MUC1 monoclonal antibodies, evaluate its role in autoantibody responses, and determine the utility of MUC1-related DNA in serum as a prognostic marker.MUC1 expression was evaluated using ELISA, FACS analysis, and immunofluorescence microscopy, revealing the highest levels in T-47D and MCF-7wt cells, followed by MCF-7adr and MDA-231. The susceptibility of these cell lines to complement-dependent lysis was tested using murine IgG and IgM anti-MUC1 monoclonal antibodies. Only T-47D cells exhibited evidence of complement-dependent lysis, which was enhanced but not significantly increased by neuraminidase treatment, indicating that sialic acid removal does not markedly improve cytotoxicity. The study also explored the relationship between MUC1 expression and estrogen receptor (ER) status in breast cancer cell lines. Oestradiol-17β, a representative steroid hormone, did not influence MUC1 expression in either ER+ (T-47D and MCF-7wt) or ER- (MDA-231) cell lines. MUC1 expression levels correlated with cell number, as shown by ELISA and MTT assays. Epitope mapping revealed that murine monoclonal antibodies raised against MUC1 recognize linear epitopes within the protein core, with a common arginine residue being a key feature. Analysis of anti-MUC1 antibodies and Pepscan techniques identified frequently recognized epitopes, including RPAPGS, PDTRP, and PPAHGVT. Serum samples from advanced breast cancer patients and those treated with a synthetic peptide vaccine were examined for reactivity to MUC1 antigens. Advanced cancer patients exhibited higher reactivity to tumor-associated MUC1, while vaccinated patients showed increased sensitivity to synthetic peptide targets. Despite detecting free MUC1 DNA in the serum of breast cancer patients, it was not a reliable diagnostic marker due to its presence in normal individuals. This research aims to enhance the understanding of MUC1 as a diagnostic and therapeutic target in breast cancer, providing insights into effective strategies for monitoring and treating the disease.

Degree

thesis:*
Grantor dc:publisher
Institutes outside Greece
Year dc:date
1998

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Petrakou, Eftychia
  • Πετράκου, Ευτυχία

Subjects

dc:subject × 24

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/57415

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Petrakou, Eftychia; Πετράκου, Ευτυχία. The MUC1 mucin as a target for antibody mediated anti-tumour reactions. Institutes outside Greece, 1998. http://hdl.handle.net/10442/hedi/57415